EC Number |
Inhibitors |
Structure |
---|
2.7.1.107 | 1,2-diarachidonoyl phosphatidic acid |
about 55% relative activity in the presence of 1.5 mol% |
|
2.7.1.107 | 1-arachidoyl-2-arachidonoyl phosphatidic acid |
about 70% relative activity in the presence of 1.5 mol% |
|
2.7.1.107 | 1-palmitoyl-2-arachidonoyl phosphatidic acid |
about 50% relative activity in the presence of 1.5 mol% |
|
2.7.1.107 | 1-stearoyl-2-arachidonoyl phosphatidic acid |
about 48% relative activity in the presence of 1.5 mol% |
|
2.7.1.107 | 1-stearoyl-2-oleoyl phosphatidic acid |
about 70% relative activity in the presence of 1.5 mol% |
|
2.7.1.107 | 2,3-dioleoylglycerol |
uncompetitive inhibition of isoforms diacylglycerol kinase alpha and zeta, no inhibition of isoform epsilon. Binds to a site on the alpha and zeta isoforms that is exposed as a consequence of the substrate binding to the active site, the chiral specificity of the isoforms thus mimicks the substrate specificity |
|
2.7.1.107 | 2-arachidonoyl glycerol |
inhibitor for both of the epsilon or the zeta isoforms of diacylglycerol kinase; inhibitor for both of the epsilon or the zeta isoforms of diacylglycerol kinase |
|
2.7.1.107 | 2-oleoyl glycerol |
inhibits diacylglycerol kinase epsilon less than does 2-arachidonoyl glycerol; shows similar inhibitory potency for diacylglycerol kinase zeta as 2-arachidonoyl glycerol |
|
2.7.1.107 | 4-[bis(4-fluorophenyl)methylidene]piperidine |
- |
|
2.7.1.107 | 5-[(2E)-3-(2-furyl)prop-2-enylidene]-3-[(phenylsulfonyl)amino]2-thioxo-1,3-thiazolidin-4-one |
- |
|